Financials HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:30:02 2024-05-17 am EDT			5-day change	1st Jan Change
199.8 ^CHF	+0.91%		+0.91%	+9.42%

May. 09	HBM Healthcare Investments' Net Loss Narrows in FY24	MT
May. 08	HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,320	2,313	1,920	1,489	1,338	1,381	-
Enterprise Value (EV) ¹	1,320	2,409	2,064	1,632	1,338	1,328	1,306
P/E ratio	7.24 x	3.06 x	-24.6 x	-10.2 x	-1,210 x	82.6 x	13.6 x
Yield	4.05%	3.76%	3.51%	3.5%	-	2.81%	2.81%
Capitalization / Revenue	-	-	-51.2 x	-12.8 x	449 x	30 x	10.5 x
EV / Revenue	-	-	-55 x	-14 x	449 x	28.8 x	9.97 x
EV / EBITDA	7.13 x	3.18 x	-27.4 x	-11.2 x	2,573 x	73.8 x	12.7 x
EV / FCF	-20.6 x	43.2 x	-34.3 x	18.3 x	-	21.5 x	21.1 x
FCF Yield	-4.86%	2.31%	-2.92%	5.46%	-	4.66%	4.74%
Price to Book	1.01 x	1.08 x	0.97 x	0.84 x	-	0.85 x	0.82 x
Nbr of stocks (in thousands)	6,947	6,957	6,957	6,957	6,911	6,911	-
Reference price ²	190.0	332.5	276.0	214.0	193.6	199.8	199.8
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	-	-37.5	-116.5	2.982	46.1	131
EBITDA ¹	185.1	758.7	-75.31	-146.1	0.52	18	103
EBIT ¹	185.1	758.7	-75.31	-146.1	0.52	18	103
Operating Margin	-	-	200.85%	125.35%	17.44%	39.05%	78.63%
Earnings before Tax (EBT) ¹	182.7	756.3	-78.03	-145.3	-1.083	18	103
Net income ¹	183	756.3	-78.03	-145.3	-1.083	18	103
Net margin	-	-	208.1%	124.67%	-36.32%	39.05%	78.63%
EPS ²	26.26	108.7	-11.22	-20.98	-0.1600	2.420	14.68
Free Cash Flow ¹	-64.16	55.77	-60.2	89.12	-	61.9	61.9
FCF margin	-	-	160.54%	-76.48%	-	134.27%	47.25%
FCF Conversion (EBITDA)	-	7.35%	-	-	-	343.89%	60.1%
FCF Conversion (Net income)	-	7.37%	-	-	-	343.89%	60.1%
Dividend per Share ²	7.700	12.50	9.700	7.500	-	5.620	5.620
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	96.2	144	143	-	-	-
Net Cash position ¹	-	-	-	-	-	53	75
Leverage (Debt/EBITDA)	-	0.1268 x	-1.906 x	-0.982 x	-	-	-
Free Cash Flow ¹	-64.2	55.8	-60.2	89.1	-	61.9	61.9
ROE (net income / shareholders' equity)	-	-	-	-	-	-	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-
Book Value Per Share ²	188.0	309.0	286.0	255.0	-	234.0	243.0
Cash Flow per Share	-	-	-	-	-	-	-
Capex	-	-	-	-	-	-	-
Capex / Sales	-	-	-	-	-	-	-
Announcement Date	5/8/20	5/27/21	5/18/22	5/26/23	5/8/24	-	-

¹CHF in Million²CHF

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

D+

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

199.8 CHF

Average target price

236 CHF

Spread / Average Target

+18.12%

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+9.42%	1.52B
HERCULES CAPITAL, INC.	+16.14%	3.1B
UMBRA COMPANIES INC.	+12.82%	1.77B
OCTOPUS TITAN VCT PLC	-11.54%	1.2B
MOLTEN VENTURES PLC	+16.35%	771M
CION INVESTMENT CORPORATION	+10.17%	671M
VERUSA HOLDING	+31.22%	562M
OCTOPUS APOLLO VCT PLC	-4.17%	505M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+27.48%	472M
BITCOIN GROUP SE	+73.57%	321M